Diagnosis and management of miliary tuberculosis: Current state and future perspectives

Therapeutics and Clinical Risk Management

Volumn 9, Issue 1, 2013, Pages 9-26

  Ray, Sayantan ^a   Talukdar, Arunansu ^a   Kundu, Supratip ^a   Khanra, Dibbendhu ^a   Sonthalia, Nikhil ^a  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Antituberculosis drugs; Biomarkers; Diagnostic tests; Human immunodeficiency virus; Mycobacterium tuberculosis; Vaccine

Indexed keywords

CORTICOSTEROID; ETHAMBUTOL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ISONIAZID; PROTEINASE INHIBITOR; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; TUBERCULOSTATIC AGENT;

AGE DISTRIBUTION; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FIBEROPTIC BRONCHOSCOPY; FLUORESCENCE MICROSCOPY; GAS EXCHANGE; HEPATOSPLENOMEGALY; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENCE; INTERFERON GAMMA RELEASE ASSAY; LUNG FUNCTION TEST; LYMPHADENOPATHY; MILIARY TUBERCULOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; REVIEW; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; THORAX RADIOGRAPHY; TISSUE DISTRIBUTION; TUBERCULIN TEST;

EID: 84873151996     PISSN: 11766336     EISSN: 1178203X     Source Type: Journal    
DOI: 10.2147/tcrm.s29179     Document Type: Review

References (148)

1. World Health Organization. WHO Report: Global Tuberculosis Control. Geneva: World Health Organization; 2011.
2. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349: 1436-1442.
3. Sahn SA, Neff TA. Miliary tuberculosis. Am J Med. 1974;56: 495-505.
4. Sharma SK, Mohan A. Disseminated and miliary tuberculosis. In: Sharma SK, Mohan A, editors. Tuberculosis, 2nd ed. New Delhi: Jaypee Brothers; 2009:493-518.
5. Baker SK, Glassroth J. Miliary tuberculosis. In: Rom WN, Garay SM, editors. Tuberculosis. Philadelphia: Lippincott Williams & Wilkins; 2004:427-444.
6. Divinagracia R, Harris HW. Miliary tuberculosis. In: Schlossberg D, editor. Tuberculosis and Nontuberculous Mycobacterial Infection. Philadelphia: WB Saunders; 1999:271-284.
7. Matsushima T. Miliary tuberculosis or disseminated tuberculosis. Int Med. 2005;44:687.
8. World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing. Geneva: WHO; 2008.
9. National AIDS Control Organisation. HIV Sentinel Surveillance and HIV Estimation in India 2007: A Technical Brief. 2008. Available from: http://www.nacoonline.org/upload/Publication/M&ESurveillance, Research/HIVSentinelSurveillanceandHIVEstimation2007_A Technical Brief.pdf. Accessed November 15, 2012.
10. Centers for Disease Control and Prevention. Reported Tuberculosis in the United States, 2010. Atlanta, GA: CDC; 2011.
11. Directorate General of Health Services. Ministry of Health and Family Welfare. RNTCP Performance Report, India, fourth quarter. New Delhi: Ministry of Health and Family Welfare; 2004.
12. Wares F, Balasubramanian R, Mohan A, Sharma SK. Extrapulmonary tuberculosis: management and control. In: Agarwal SP, Chauhan LS, editors. Tuberculosis Control in India. New Delhi: Elsevier; 2005:95-114.
13. [No authors listed.] National survey of notifications of tuberculosis in England and Wales in 1988. Medical Research Council Cardiothoracic Epidemiology Group. Thorax. 1992;47:770-775.
14. Shafer RW, Kim DS, Weiss JP, Quale JM. Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine (Baltimore). 1991;70:384-397.
15. Jones BE, Young SM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis. 1993;148:1292-1297.
16. Lee MP, Chan JW, Ng KK, Li PC. Clinical manifestations of tuberculosis in HIV-infected patients. Respirology. 2000;5:423-426.
17. Sharma SK, Mohan A. Extrapulmonary tuberculosis. Indian J Med Res. 2004;120:316-353.
18. Shao C, Qu J, He L. A comparative study of clinical manifestations caused by tuberculosis in immunocompromised and non-immunocompromised patients. Chin Med J. 2003;116:1717-1722.
19. Jacques J, Sloan JM. The changing pattern of miliary tuberculosis. Thorax. 1970;25:237-240.
20. [No authors listed.] Miliary tuberculosis: a changing pattern [editorial]. Lancet. 1975;1:985-986.
21. Proudfoot AT, Akhtar AJ, Doughs AC, Home NW. Miliary tuberculosis in adults. Br Med J. 1969;2:273-276.
22. Braun MM, Cote TR, Rabkin CS. Trends in death with tuberculosis during the AIDS era. JAMA. 1993;269:2865-2868.
23. Slavin RE, Walsh TJ, Pollack AD. Late generalized tuberculosis: a clinical pathologic analysis and comparison of 100 cases in the preantibiotic and antibiotic eras. Medicine (Baltimore). 1980;59:352-366.
24. Long R, O'Connor R, Palayew M, Hershfield E, Manfreda J. Disseminated tuberculosis with and without a miliary pattern on chest radiograph: a clinical-pathologic-radiologic correlation. Int J Tuberc Lung Dis. 1997;1:52-58.
25. Biehl JP. Miliary tuberculosis; a review of sixty-eight adult patients admitted to a municipal general hospital. Am Rev Tuberc. 1958;77: 605-622.
26. Munt PW. Miliary tuberculosis in the chemotherapy era: with a clinical review in 69 American adults. Medicine (Baltimore). 1972;51: 139-155.
27. Campbell IG. Miliary tuberculosis in British Columbia. Can Med Assoc J. 1973;108:1517-1519.
28. Gelb AF, Leffler C, Brewin A, Mascatello V, Lyons HA. Miliary tuberculosis. Am Rev Respir Dis. 1973;108:1327-1333.
29. Grieco MH, Chmel H. Acute disseminated tuberculosis as a diagnostic problem. A clinical study based on twenty-eight cases. Am Rev Respir Dis. 1974;109:554-560.
30. Onadeko BO, Dickinson R, Sofowora EO. Miliary tuberculosis of the lung in Nigerian adults. East Afr Med J. 1975;52:390-395.
31. Teklu B, Butler J, Ostrow JH. Miliary tuberculosis. A review of 83 cases treated between 1950 and 1968. Ethiop Med J. 1977;15:39-48.
32. Prout S, Benatar SR. Disseminated tuberculosis. A study of 62 cases. S Afr Med J. 1980;58:835-842.
33. Kim JH, Langston AA, Gallis HA. Miliary tuberculosis: epidemiology, clinical manifestations, diagnosis, and outcome. Rev Infect Dis. 1990;12: 583-590.
34. Maartens G, Willcox PA, Benatar SR. Miliary tuberculosis: rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults. Am J Med. 1990;89:291-296.
35. Sharma SK, Mohan A, Pande JN, Prasad KL, Gupta AK, Khilnani GC. Clinical profile, laboratory characteristics and outcome in miliary tuberculosis. QJM. 1995;88:29-37.
36. Al-Jahdali H, Al-Zahrani K, Amene P, et al. Clinical aspects of miliary tuberculosis in Saudi adults. Int J Tuberc Lung Dis. 2000;4:252-255.
37. Mert A, Bilir M, Tabak F, et al. Miliary tuberculosis: clinical manifestations, diagnosis and outcome in 38 adults. Respirology. 2001;6:217-224.
38. Hussain SF, Irfan M, Abbasi M, et al. Clinical characteristics of 110 miliary tuberculosis patients from a low HIV prevalence country. Int J Tuberc Lung Dis. 2004;8:493-499.
39. Collins HL, Kaufmann SH. The many faces of host responses to tuberculosis. Immunology. 2001;103:1-9.
40. Rook GA, Hernandez-Pando R, Dheda K, Teng Seah G. IL-4 in tuberculosis: implications for vaccine design. Trends Immunol. 2004;25: 483-488.
41. Sharma PK, Saha PK, Singh A, Sharma SK, Ghosh B, Mitra DK. FoxP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis. Am J Respir Crit Care Med. 2009;179: 1061-1070.
42. Sharma SK, Mitra DK, Balamurugan A, Pandey RM, Mehra NK. Cytokine polarization in miliary and pleural tuberculosis. J Clin Immunol. 2002;22:345-352.
43. Cunha BA, Krakakis J, McDermott BP. Fever of unknown origin (FUO) caused by miliary tuberculosis: diagnostic significance of morning temperature spikes. Heart Lung. 2009;38:77-82.
44. Yu YL, Chow WH, Humphries MJ, Wong RW, Gabriel M. Cryptic miliary tuberculosis. QJM. 1986;59:421-428.
45. Ormerod LP. Respiratory tuberculosis. In: Davies PDO, editor. Clinical Tuberculosis. London: Chapman and Hall Medical; 1997:76.
46. Sharma SK, Mohan A. Miliary tuberculosis. In: Schlossberg D, editor. Tuberculosis and Nontuberculous Mycobacterial Infections, 6th ed. Washington: American Society for Microbiology; 2011:415-435.
47. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351:1741-1751.
48. Garg RK, Sharma R, Kar AM, et al. Neurological complications of miliary tuberculosis. Clin Neurol Neurosurg. 2010;112:188-192.
49. Braidy J, Pothel C, Amra S. Miliary tuberculosis presenting as adrenal failure. Can Med Assoc J. 1981;124:748-751.
50. Penner C, Roberts D, Kunimoto D, Manfreda J, Long R. Tuberculosis as a primary cause of respiratory failure requiring mechanical ventilation. Am J Respir Crit Care Med. 1995;151:867-872.
51. Mohan A, Sharma SK, Pande JN. Acute respiratory distress syndrome in miliary tuberculosis: a 12-year experience. Indian J Chest Dis Allied Sci. 1996;38:157-162.
52. Sharma N, Kumar P. Miliary tuberculosis with bilateral pneumothorax: a rare complication. Indian J Chest Dis Allied Sci. 2002;44:125-127.
53. Das M, Chandra U, Natchu M, Lodha R, Kabra SK. Pneumomediastinum and subcutaneous emphysema in acute miliary tuberculosis. Indian J Pediatr. 2004;71:553-554.
54. Singh KJ, Ahluwalia G, Sharma SK, Saxena R, Chaudhary VP, Anant M. Significance of haematological manifestations in patients with tuberculosis. J Assoc Physicians India. 2001;49:788, 790-794.
55. Kuo PH, Yang PC, Kuo SS, Luh KT. Severe immune hemolytic anemia in disseminated tuberculosis with response to antituberculosis therapy. Chest. 2001;119:1961-1963.
56. Runo JR, Welch DC, Ness EM, Robbins IM, Milstone AP. Miliary tuberculosis as a cause of acute empyema. Respiration. 2003;70:529-532.
57. Sydow M, Schauer A, Crozier TA, Burchardi H. Multiple organ failure in generalized disseminated tuberculosis. Respir Med. 1992;86: 517-519.
58. Nieuwland Y, Tan KY, Elte JW. Miliary tuberculosis presenting with thyrotoxicosis. Postgrad Med J. 1992;68:677-679.
59. Mallinson WJ, Fuller RW, Levison DA, Baker LR, Cattell WR. Diffuse interstitial renal tuberculosis-an unusual cause of renal failure. QJM. 1981;50:137-148.
60. Shribman JH, Eastwood JB, Uff J. Immune complex nephritis complicating miliary tuberculosis. Br Med J (Clin Res Ed). 1983;287: 1593-1594.
61. Wallis PJ, Branfoot AC, Emerson PA. Sudden death due to myocardial tuberculosis. Thorax. 1984;39:155-156.
62. Felson B, Akers PV, Hall GS, Schreiber JT, Greene RE, Pedrosa CS. Mycotic tuberculous aneurysm of the thoracic aorta. JAMA. 1977;237: 1104-1108.
63. Cope AP, Heber M, Wilkins EG. Valvular tuberculous endocarditis: a case report and review of the literature. J Infect. 1990;21:293-296.
64. Wainwright J. Tuberculous endocarditis: a report of 2 cases. S Afr Med J. 1979;56:731-733.
65. Rose AG. Cardiac tuberculosis. A study of 19 patients. Arch Pathol Lab Med. 1987;111:422-426.
66. Asada Y, Hayashi T, Sumiyoshi A, Aburaya M, Shishime E. Miliary tuberculosis presenting as fever and jaundice with hepatic failure. Hum Pathol. 1991;22:92-94.
67. Hussey G, Chisholm T, Kibel M. Miliary tuberculosis in children: a review of 94 cases. Pediatr Infect Dis J. 1991;10:832-836.
68. Kim PK, Lee JS, Yun DJ. Clinical review of miliary tuberculosis in Korean children. 84 cases and review of the literature. Yonsei Med J. 1969;10:146-152.
69. Gurkan F, Bosnak M, Dikici B, et al. Miliary tuberculosis in children: a clinical review. Scand J Infect Dis. 1998;30:359-362.
70. Aderele WI. Miliary tuberculosis in Nigerian children. East Afr Med J. 1978;55:166-171.
71. Rahajoe NN. Miliary tuberculosis in children. A clinical review. Paediatr Indones. 1990;30:233-240.
72. Sharma SK, Mohan A. Co-infection of human immunodeficiency virus (HIV) and tuberculosis: Indian perspective. Indian J Tuberc. 2004;51: 5-16.
73. Haas DW, Des Prez RM. Tuberculosis and acquired immunodeficiency syndrome: a historical perspective on recent developments. Am J Med. 1994;96:439-450.
74. Theuer CP, Hopewell PC, Elias D, Schecter GF, Rutherford GW, Chaisson RE. Human immunodeficiency virus infection in tuberculosis patients. J Infect Dis. 1990;162:8-12.
75. Lado Lado FL, Barrio Gomez E, Carballo Arceo E, Cabarcos Ortiz de Barron A. Clinical presentation of tuberculosis and the degree of immunodeficiency in patients with HIV infection. Scand J Infect Dis. 1999;31:387-391.
76. Kim JY, Jeong YJ, Kim KI, et al. Miliary tuberculosis: a comparison of CT findings in HIV-seropositive and HIV-seronegative patients. Br J Radiol. 2010;83:206-11.
77. Harries A, Maher D, Graham S. TB/HIV: A Clinical Manual, 2nd ed. Geneva: World Health Organization; 2004.
78. Daikos GL, Uttamchandani RB, Tuda C, et al. Disseminated miliary tuberculosis of the skin in patients with AIDS: report of four cases. Clin Infect Dis. 1998;27:205-208.
79. del Giudice P, Bernard E, Perrin C, et al. Unusual cutaneous manifestations of miliary tuberculosis. Clin Infect Dis. 2000;30:201-204.
80. Crump JA, Tyrer MJ, Lloyd-Owen SJ, Han LY, Lipman MC, Johnson MA. Miliary tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy. Clin Infect Dis. 1998;26:1008-1009.
81. Jehle AW, Khanna N, Sigle JP, et al. Acute renal failure on immune reconstitution in an HIV-positive patient with miliary tuberculosis. Clin Infect Dis. 2004;38:e32-e35.
82. Goldsack NR, Allen S, Lipman MC. Adult respiratory distress syndrome as a severe immune reconstitution disease following the commencement of highly active antiretroviral therapy. Sex Transm Infect. 2003;79: 337-338.
83. Willcox PA, Potgieter PD, Bateman ED, Benatar SR. Rapid diagnosis of sputum negative miliary tuberculosis using the flexible fibreoptic bronchoscope. Thorax. 1986;41:681-684.
84. Rodrigues C, Shenai S, Sadani M, et al. Evaluation of the bactec MGIT 960 TB system for recovery and identification of Mycobacterium tuberculosis complex in a high through put tertiary care centre. Indian J Med Microbiol. 2009;27:217-221.
85. Rosenberg MJ, Rumans LW. Survival of a patient with pancytopenia and disseminated coagulation associated with miliary tuberculosis. Chest. 1978;73:536-539.
86. Cattamanchi A, Smith R, Steingart KR, et al. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr. 2011;56:230-238.
87. Mori T. Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays. J Infect Chemother. 2009;15:143-145.
88. World Health Organization. Use of Interferon-γ Release Assays (IGRAs) in TB Control in Low and Middle-Income Settings. Geneva: WHO; 2010.
89. Steiner PE. The histopathological basis for the X-ray diagnosability of pulmonary miliary tuberculosis. Am Rev Tuberc. 1937;36:692-705.
90. Kwong JS, Carignan S, Kang EY, Müller NL, FitzGerald JM. Miliary tuberculosis. Diagnostic accuracy of chest radiography. Chest. 1996;110:339-342.
91. Jamieson DH, Cremin BJ. High resolution CT of the lungs in acute disseminated tuberculosis and a pediatric radiology perspective of the term "miliary. " Pediatr Radiol. 1993;23:380-383.
92. Price M. Lymphangitis reticularis tuberculosa. Tubercle. 1968;49: 377-384.
93. Van Dyck P, Vanhoenacker FM, Van den Brande P, et al. Imaging of pulmonary tuberculosis. Eur Radiol. 2003;13:1771-1785.
94. McGuinness G, Naidich DP, Jagirdar J, Leitman B, McCauley DI. High resolution CT findings in miliary lung disease. J Comput Assist Tomogr. 1992;16:384-390.
95. Pipavath SNJ, Sharma SK, Sinha S, Mukhopadhyay S, Gulati MS. High resolution CT (HRCT) in miliary tuberculosis (MTB) of the lung: correlation with pulmonary function tests and gas exchange parameters in north Indian patients. Indian J Med Res. 2007;126:193-198.
96. Yu RS, Zhang SZ, Wu JJ, Li RF. Imaging diagnosis of 12 patients with hepatic tuberculosis. World J Gastroenterol. 2004;10:1639-1642.
97. Ichiya Y, Kuwabara Y, Sasaki M, et al. FDG-PET in infectious lesions: the detection and assessment of lesion activity. Ann Nucl Med. 1996;10: 185-191.
98. Goo JM, Im JG, Do KH, et al. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology. 2000;216: 117-121.
99. Williams NH Jr, Kane C, Yoo OH. Pulmonary function in miliary tuberculosis. Am Rev Respir Dis. 1973;107:858-860.
100. Ainslie GM, Solomon JA, Bateman ED. Lymphocyte and lymphocyte subset numbers in blood and in bronchoalveolar lavage and pleural fluid in various forms of pulmonary tuberculosis at presentation and during recovery. Thorax. 1992;47:513-518.
101. Sharma SK, Pande JN, Singh YN, et al. Pulmonary function and immunologic abnormalities in miliary tuberculosis. Am Rev Respir Dis. 1992;145(5):1167-1171.
102. Sharma SK, Ahluwalia G. Exercise testing in miliary tuberculosis-some facts. Indian J Med Res. 2007;125:182-183.
103. Sharma SK, Ahluwalia G. Effect of antituberculosis treatment on cardiopulmonary responses to exercise in miliary tuberculosis. Indian J Med Res. 2006;124:411-418.
104. Lange C, Mori T. Advances in the diagnosis of tuberculosis. Respirology. 2010;15:220-240.
105. Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC. International standards for tuberculosis care. Lancet Infect Dis. 2006;6: 710-725.
106. Moore DA, Mendoza D, Gilman RH, et al. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol. 2004;42:4432-4437.
107. Moore DA, Evans CA, Gilman RH, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med. 2006;355:1539-1550.
108. Shikama ML, Ferro e Silva R, Villela G, et al. Multicentre study of nitrate reductase assay for rapid detection of rifampicin-resistant M. tuberculosis. Int J Tuberc Lung Dis. 2009;13:377-380.
109. Sharma SK, Pande JN, Verma K. Bronchoalveolar lavage (BAL) in miliary tuberculosis. Tubercle. 1988;69:175-178.
110. Prabhakaran D, Sharma SK, Verma K, Pande JN. Estimation of fibronectin in bronchoalveolar lavage fluid in various diffuse interstitial lung diseases. Am Rev Respir Dis. 1990;141:A51.
111. Sharma SK, Suresh V, Mohan A, et al. A prospective study of sensitivity and specificity of adenosine deaminase estimation in the diagnosis of tuberculosis pleural effusion. Indian J Chest Dis Allied Sci. 2001;43: 149-155.
112. Sharma SK, Banga A. Diagnostic utility of pleural fluid IFN-gamma in tuberculosis pleural effusion. J Interferon Cytokine Res. 2004;24: 213-217.
113. Sharma SK, Banga A. Pleural fluid interferon-gamma and adenosine deaminase levels in tuberculosis pleural effusion: a cost-effectiveness analysis. J Clin Lab Anal. 2005;19:40-46.
114. Rana SV, Chacko F, Lal V, et al. To compare CSF adenosine deaminase levels and CSF-PCR for tuberculous meningitis. Clin Neurol Neurosurg. 2010;112:424-430.
115. World Health Organization. Policy statement. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB). 2008. Available from: http://www.who.int/tb/features_archive/policy_statement.pdf. Accessed July 19, 2012.
116. Kanduma E, McHugh TD, Gillespie SH. Molecular methods for Mycobacterium tuberculosis strain typing: a users guide. J Appl Microbiol. 2003;94:781-791.
117. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363: 1005-1015.
118. Helb D, Jones M, Story E, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2010;48:229-237.
119. Minion J, Leung E, Talbot E, Dheda K, Pai M, Menzies D. Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis. Eur Respir J. 2011;38:1398-1405.
120. Lawn SD, Kerkhoff AD, Vogt M, Wood R. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis. 2011;12:201-209.
121. Weyer K, Carai S, Nunn P. TB diagnostics-what does the world really need? J Infect Dis. 2011;204 Suppl 4:S1196-S1202.
122. Ghanashyam B. Tuberculosis diagnostics: innovating to make an impact. Expert Rev Anti Infect Ther. 2011;9:381-384.
123. World Health Organization. Treatment of Tuberculosis: Guidelines for National Programmes, 3rd ed. Geneva: WHO; 2003.
124. World Health Organization. Treatment of Tuberculosis: Guidelines, 4th ed. Geneva: WHO; 2009.
125. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167:603-662.
126. National Institute for Health and Clinical Excellence, National Collaborating Centre for Chronic Conditions. Management of non-respiratory tuberculosis. In: Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control. London: Royal College of Physicians; 2006:63-76.
127. [No authors listed.] American Academy of Pediatrics Committee on Infectious Diseases: Chemotherapy for tuberculosis in infants and children. Pediatrics. 1992;89:161-165.
128. World Health Organization. Rapid Advice: Antiretroviral Therapy for HIV Infection in Adults and Adolescents. Geneva: WHO; 2009.
129. Sharma SK, Mohan A, Kadhiravan T. HIV-TB co-infection: epidemiology, diagnosis and management. Indian J Med Res. 2005;121:550-567.
130. Pozniak AL, Coyne KM, Miller RF, et al. BHIVA treatment guidelines for (TB)/HIV infection 2005. HIV Med. 2011;12:517-524.
131. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-926.
132. Dooley DP, Carpenter JL, Rademacher S. Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clin Infect Dis. 1997;25:872-887.
133. Sun TN, Yang JY, Zheng LY, Deng WW, Sui ZY. Chemotherapy and its combination with corticosteroids in acute miliary tuberculosis in adolescents and adults: analysis of 55 cases. Chin Med J (Engl). 1981;94:309-314.
134. Massaro D, Katz S, Sachs M. Choroidal tubercles. A clue to hematogenous tuberculosis. Ann Intern Med. 1964;60:231-241.
135. Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta analysis. Int J Epidemiol. 1993;22:1154-1158.
136. Leyten EM, Lin MY, Franken KL, et al. Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect. 2006;8:2052-2060.
137. Murray RA, Mansoor N, Harbacheuski R, et al. Bacillus Calmette Guerin vaccination of human newborns induces a specific, functional CD8+ T cell response. J Immunol. 2006;177:5647-5651.
138. Kaufmann SH, Hussey G, Lambert PH. New vaccines for tuberculosis. Lancet. 2010;375:2110-2119.
139. Parida SK, Kaufmann SH. Novel tuberculosis vaccines on the horizon. Curr Opin Immunol. 2010;22:374-384.
140. Miyoshi I, Daibata M, Kuroda N, Taguchi H, Enzan H. Miliary tuberculosius not affecting the lungs but complicated by acute respiratory distress syndrome. Intern Med. 2005;44:622-624.
141. Kim DK, Kim HJ, Kwon SY, et al. Nutritional deficit as a negative prognostic factor in patients with miliary tuberculosis. Eur Respir J. 2008;32:1031-1036.
142. Wilcox PA, Ferguson AD. Chronic obstructive airways disease following treated pulmonary tuberculosis. Respir Med. 1989;83:195-198.
143. Hnzido E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. 2000;55:32-38.
144. Ohi M, Chin K, Tsutsui T, Fukunaga T, Kuno K. Tuberculosis sequelae: pathophysiological aspect (ventilation). Kekkaku. 1990;65:847-854. Japanese.
145. Pasipanodya JG, Miller TL, Vecino M, et al. Pulmonary impairment after tuberculosis. Chest. 2007;131:1817-1824.
146. Kuijl C, Savage ND, Marsman M, et al. Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1. Nature. 2007;450: 725-730.
147. Loebinger MR, Janes SMJ. Stem cells for lung diseases. Chest. 2007; 132:279-285.
148. Mwaba P, McNerney R, Grobusch MP, et al. Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis. Trop Med Int Health. 2011;16: 819-827.